In silico study of some selective phytochemicals against a hypothetical SARS-CoV-2 spike RBD using molecular docking tools. - Anish Nag; Subhabrata Paul; Ritesh Banerjee; Rita Kundu (Comput. Biol. Medicine, 2021)

Network pharmacological evaluation for identifying novel drug-like molecules from ginger (Zingiber officinale Rosc.) against multiple disease targets, a computational biotechnology approach. - Anish Nag; Ritesh Banerjee (Netw. Model. Anal. Health Informatics Bioinform., 2021)

Curcumin inhibits spike protein of new SARS-CoV-2 variant of concern (VOC) Omicron, an in silico study. - Anish Nag; Ritesh Banerjee; Subhabrata Paul; Rita Kundu (Comput. Biol. Medicine, 2022)

An in-silico pharmacophore-based molecular docking study to evaluate the inhibitory potentials of novel fungal triterpenoid Astrakurkurone analogues against a hypothetical mutated main protease of SARS-CoV-2 virus. - Anish Nag; Adhiraj Dasgupta; Sutirtha Sengupta; Tapan Kumar Lai; Krishnendu Acharya (Comput. Biol. Medicine, 2023)

A top-down approach for studying the in-silico effect of the novel phytocompound tribulusamide B on the inhibition of Nipah virus transmission through targeting fusion glycoprotein and matrix protein. - Deblina Rababi; Anish Nag (Comput. Biol. Chem., 2024)